HUMIRA (adalimumab) is a prescription injection medication used to treat various forms of arthritis , including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is also used to treat other inflammatory conditions such as Crohn's disease, ulcerative colitis, and plaque psoriasis.
Adalimumab works by reducing inflammation in the body, which can help relieve symptoms of joint pain, stiffness, and swelling. It is a biologic drug that targets the tumor necrosis factor alpha (TNF-alpha) protein in the body, which plays a role in causing inflammation.
While HUMIRA can be effective for those suffering from arthritis and other inflammatory conditions, it is important to note that it can have side effects. The most common side effects include injection site reactions such as pain, swelling, and redness, as well as headache, upper respiratory infections, and rash.
It is recommended that patients who are considering or are taking HUMIRA should be monitored closely by their healthcare provider, as they may need to adjust the dosage or switch to a different medication if it is not effective or if side effects become too severe.
Additionally, patients taking HUMIRA should be aware of any potential interactions between the medication and other drugs they may be taking, and they should inform their healthcare provider of all medications and supplements they are taking.
Overall, while HUMIRA can be an effective treatment for arthritis and other inflammatory conditions, it is important for patients to be informed of its potential risks and side effects, and to work closely with their healthcare provider to monitor their condition and make any necessary adjustments to their treatment plan.
HUMIRA is a brand name for adalimumab, a prescription medication used to treat autoimmune conditions such as arthritis and psoriasis. It is manufactured by the global pharmaceutical company AbbVie.Art...